Vimarsana
Biggest News Aggregation in the World

Tal Hasin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tal Hasin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tal Hasin Today - Breaking & Trending Today

Israeli Scientists Find Connection Between Heart Attacks and Cancer - Vimarsana News

Israeli Scientists Find Connection Between Heart Attacks and Cancer

Patients with heart disease are at a higher risk of developing cancer, and since heart disease is already a leading cause of death

Children of asylum seekers to be integrated into Tel Aviv schools - Vimarsana News

Children of asylum seekers to be integrated into Tel Aviv schools

96 refugee children will be part of a pilot scheme to test whether their integration into the wider education system would be beneficial.

Source: jpost.com
Israeli Education Ministry Promotes Plan to Integrate Foreign Children in North Tel Aviv - Israel News - Vimarsana News

Israeli Education Ministry Promotes Plan to Integrate Foreign Children in North Tel Aviv - Israel News

The Plan, Being Promoted by Israel's Education Minister Yoav Kisch Will Reduce the Number of Students in Non-segregated Schools in the City's South, Sending a Small Number to the North and Others to Schools With Foreign Students Only

Shaare Zedek among the few to launch catheterization for heart failure - Vimarsana News

Shaare Zedek among the few to launch catheterization for heart failure

Patients with moderately severe valvular stenosis who have not been treated so far will be catheterized and will be able to return to full function.

Source: jpost.com
Data from Israel: myocarditis after COVID-19 vaccines remain rare, highest risk in young males - Vimarsana News

Data from Israel: myocarditis after COVID-19 vaccines remain rare, highest risk in young males

A new study from Israel found that the risk of developing myocarditis among males ages 16 to 19 years was about 1 in 15,000 after third dose of the Pfizer-BioNT